Dizziness: Changes in nitric oxide levels lead to lightheadedness immediately after administration
Recalls & Warnings May 24, 2013 Maker of Neuropathic Pain Product Warned For Drug Claims, Misbranding On April 11, 2013, the FDA issued a warning letter to Realm Labs, LLC, following a review of the companys websites which found statements made about its NeuRemedy products to be drug claims
It does not constitute medical advice, diagnosis, or treatment guidance
What analytical methods are used to test GHK-Cu purity
5 mg bottle $125 Active in the brain, this peptide helps modulate the functions of key areas of the brain like the hypothalamus and pineal glands
[1] Other rare side effects noted (mostly in older literature or high-dose use) include: polycythemia vera and peripheral vascular thrombosis in patients receiving repeated injections (though these associations are not well understood, they were listed in prior product literature as possible adverse events)